As September 2025 begins, the U.S. market is experiencing a downturn, particularly in the tech sector, with key indices like the S&P 500 and Nasdaq Composite showing declines amid uncertainties about tariffs and potential interest rate cuts by the Federal Reserve. In this environment, identifying high-growth tech stocks requires focusing on companies that demonstrate resilience through innovation and adaptability to shifting economic conditions.
Top 10 High Growth Tech Companies In The United States
| Name | Revenue Growth | Earnings Growth | Growth Rating |
|---|---|---|---|
| ACADIA Pharmaceuticals | 10.87% | 25.66% | ★★★★★☆ |
| ADMA Biologics | 20.60% | 23.25% | ★★★★★☆ |
| Palantir Technologies | 25.30% | 31.65% | ★★★★★★ |
| OS Therapies | 57.14% | 70.12% | ★★★★★☆ |
| Circle Internet Group | 27.36% | 77.54% | ★★★★★☆ |
| RenovoRx | 65.52% | 68.63% | ★★★★★☆ |
| Vanda Pharmaceuticals | 22.66% | 59.11% | ★★★★★☆ |
| Monopar Therapeutics | 76.01% | 54.38% | ★★★★★☆ |
| Gorilla Technology Group | 27.68% | 129.58% | ★★★★★☆ |
| Aldeyra Therapeutics | 42.88% | 74.81% | ★★★★★☆ |
Click here to see the full list of 70 stocks from our US High Growth Tech and AI Stocks screener.
Let's uncover some gems from our specialized screener.
Intapp (INTA)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Intapp, Inc. offers AI-powered solutions globally through its subsidiary, Integration Appliance, Inc., and has a market cap of $3.78 billion.
Operations: The company generates revenue primarily from its Software & Programming segment, amounting to $504.12 million.
Intapp, a player in the tech sector, recently reported a significant uptick in annual revenue to $504.12 million, marking an increase from the previous year's $430.52 million. This growth accompanies strategic executive enhancements, with Dustin Sedgwick bringing his fintech expertise from J.P. Morgan to serve as Chief Marketing Officer. Intapp is also intensifying its commitment to innovation through its Horizon release for Intapp Time, integrating advanced generative AI capabilities that are set to revolutionize timekeeping practices across top global firms. These strategic moves underscore Intapp’s focus on leveraging high-tech solutions to drive efficiency and growth within its client industries.
- Click here to discover the nuances of Intapp with our detailed analytical health report.
Understand Intapp's track record by examining our Past report.
Krystal Biotech (KRYS)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Krystal Biotech, Inc. is a commercial-stage biotechnology company focused on discovering, developing, manufacturing, and commercializing genetic medicines to address diseases with high unmet medical needs in the United States, with a market cap of $4.27 billion.
Operations: Krystal Biotech generates revenue primarily from its genetic medicines segment, with $359.21 million attributed to treating diseases with high unmet medical needs. The company's focus on this niche allows it to address significant gaps in the healthcare market within the United States.
Krystal Biotech's recent advancements underscore its potential within the biotech sector, particularly with its innovative KB707 and VYJUVEK treatments. The company's Q2 earnings soared to $38.33 million from last year's $15.57 million, reflecting a robust growth trajectory. Additionally, the strategic focus on KB707 for NSCLC treatment following promising trial outcomes—36% objective response rate—highlights its commitment to addressing critical healthcare needs through groundbreaking gene therapies. This focus is complemented by significant R&D investments aimed at enhancing product pipelines and ensuring regulatory success, positioning Krystal Biotech as a dynamic player in high-growth biotechnology markets.
- Unlock comprehensive insights into our analysis of Krystal Biotech stock in this health report.
Review our historical performance report to gain insights into Krystal Biotech's's past performance.
monday.com (MNDY)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: monday.com Ltd., along with its subsidiaries, develops software applications across various regions including the United States, Europe, the Middle East, Africa, and the United Kingdom, with a market capitalization of approximately $9.95 billion.
Operations: The company generates revenue primarily from its Internet Software & Services segment, amounting to $1.10 billion. The business focuses on software application development across multiple regions, including the U.S., Europe, the Middle East, Africa, and the U.K.
At monday.com, recent integrations and AI innovations signal a robust trajectory in the tech landscape, particularly within project management solutions. The company's recent partnership with Proggio to integrate task management features enhances operational visibility and efficiency, reflecting a strategic push towards more interconnected software ecosystems. Financially, monday.com reported a significant revenue jump to $299 million in Q2 2025 from $236 million the previous year, alongside an earnings forecast predicting continued growth with revenues potentially reaching up to $1.229 billion annually. This financial uplift is supported by innovative AI-driven tools like 'monday magic' and 'monday vibe,' which simplify complex workflows and promote scalable solutions across various business sizes—underscoring monday.com’s commitment to broadening its impact through advanced technology while catering to a diverse client base.
- Click here and access our complete health analysis report to understand the dynamics of monday.com.
Gain insights into monday.com's historical performance by reviewing our past performance report.
Make It Happen
- Navigate through the entire inventory of 70 US High Growth Tech and AI Stocks here.
- Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
- Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.
Curious About Other Options?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if monday.com might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com